CORRECTED: Endo Inks $193M Deal Over Off-Label Lidoderm Marketing
Endo Health Solutions Inc. agreed to pay nearly $193 million on Friday to settle civil whistleblower claims and criminal allegations that off-label promotion of the adhesive pain-relief patch Lidoderm induced health...To view the full article, register now.
Already a subscriber? Click here to view full article